Notice Pursuant to the National Cooperative Research and Production Act of 1993-PXI Systems Alliance, Inc., 55858 [E9-25777]

Download as PDF 55858 Federal Register / Vol. 74, No. 208 / Thursday, October 29, 2009 / Notices Maureen Katz, Assistant Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. E9–25957 Filed 10–28–09; 8:45 am] BILLING CODE 4410–15–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this is notice that on September 11, 2009, Johnson Matthey, Inc., Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the basic classes of controlled substances listed in schedule II: Schedule Drug dcolon on DSK2BSOYB1PROD with NOTICES Phenylacetone (8501) .................. Coca Leaves (9040) ..................... Thebaine (9333) ........................... Opium, raw (9600) ....................... Noroxymorphone (9668) .............. Poppy Straw Concentrate (9670) II II II II II II Dated: October 21, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–25999 Filed 10–28–09; 8:45 am] BILLING CODE 4410–09–P 15:20 Oct 28, 2009 Jkt 220001 Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—PXI Systems Alliance, Inc. Notice is hereby given that, on September 10, 2009, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), PXI Systems Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, ADLINK Technology has changed its name to Ampro ADLINK Technology, Inc. San Jose, CA. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and PXI Systems Alliance, Inc. intends to file additional written notifications disclosing all changes in membership. On November 22, 2000, PXI Systems Alliance, Inc. filed its original notification pursuant to Section 6(a) of PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on March 8, 2001 (66 FR 13971). The last notification was filed with the Department on June 22, 2009. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on August 3, 2009 (74 FR 38473). Patricia A. Brink, Deputy Director of Operations, Antitrust Division. [FR Doc. E9–25777 Filed 10–28–09; 8:45 am] BILLING CODE 4410–11–M DEPARTMENT OF LABOR Occupational Safety and Health Administration [Docket No. OSHA–2009–0033] Walking and Working Surfaces Standard for General Industry; Extension of the Office of Management and Budget’s (OMB) Approval of the Information Collection (Paperwork) Requirements AGENCY: Occupational Safety and Health Administration (OSHA), Labor. ACTION: Request for public comment. DEPARTMENT OF JUSTICE The company plans to import the listed controlled substances as raw materials for use in the manufacture of bulk controlled substances for distribution to its customers. No comments, objections, or requests for any hearings will be accepted on any application for registration or reregistration to import crude opium, poppy straw, concentrate of poppy straw, and coca leaves. As explained in the Correction to Notice of Application pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and requests for hearings on applications to import narcotic raw material are not appropriate. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances listed in schedule I or II, which fall under the authority of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in the circumstances set forth in 21 U.S.C. 958(i), file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such comments or objections should be addressed, in quintuplicate, to the Drug Enforcement VerDate Nov<24>2008 Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than November 30, 2009. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745), all applicants for registration to import a basic classes of any controlled substances in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. SUMMARY: OSHA solicits comments concerning its proposal to extend the Office of Management and Budget’s (OMB) approval of the information collection requirements contained in the Walking and Working Surfaces Standard for General Industry (29 CFR part 1910, subpart D). DATES: Comments must be submitted (postmarked, sent, or received) by December 28, 2009. ADDRESSES: Electronically: You may submit comments and attachments electronically at https:// www.regulations.gov, which is the Federal eRulemaking Portal. Follow the instructions online for submitting comments. Facsimile: If your comments, including attachments, are not longer than 10 pages, you may fax them to the OSHA Docket Office at (202) 693–1648. Mail, hand delivery, express mail, messenger, or courier service: When using this method, you must submit three copies of your comments and attachments to the OSHA Docket Office, Docket No. OSHA–2009–0033, U.S. Department of Labor, Occupational Safety and Health Administration, Room N–2625, 200 Constitution E:\FR\FM\29OCN1.SGM 29OCN1

Agencies

[Federal Register Volume 74, Number 208 (Thursday, October 29, 2009)]
[Notices]
[Page 55858]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-25777]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--PXI Systems Alliance, Inc.

    Notice is hereby given that, on September 10, 2009, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), PXI Systems Alliance, Inc. 
has filed written notifications simultaneously with the Attorney 
General and the Federal Trade Commission disclosing changes in its 
membership. The notifications were filed for the purpose of extending 
the Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances. Specifically, ADLINK 
Technology has changed its name to Ampro ADLINK Technology, Inc. San 
Jose, CA.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and PXI Systems Alliance, Inc. intends 
to file additional written notifications disclosing all changes in 
membership.
    On November 22, 2000, PXI Systems Alliance, Inc. filed its original 
notification pursuant to Section 6(a) of the Act. The Department of 
Justice published a notice in the Federal Register pursuant to Section 
6(b) of the Act on March 8, 2001 (66 FR 13971).
    The last notification was filed with the Department on June 22, 
2009. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on August 3, 2009 (74 FR 38473).

Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. E9-25777 Filed 10-28-09; 8:45 am]
BILLING CODE 4410-11-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.